Lauren E. Brown, Ph.D.

Affiliations: 
University of California, Santa Cruz, Santa Cruz, CA, United States 
Area:
Synthetic organic chemistry; heterocyclic chemistry, bio-organic chemistry
Google:
"Lauren Brown"
Mean distance: 9.63
 
SNBCP

Parents

Sign in to add mentor
Nicos A. Petasis research assistant 2001-2003 USC
Joseph P. Konopelski grad student 2009 UC Santa Cruz
 (Synthetic studies toward welwistatin, psymberin and a protective pharmaceutical.)
Scott E. Schaus post-doc 2009-2012 Boston University
John A. Porco research scientist 2012-2014 Boston University
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Fallah S, Duncan D, Reichl KD, et al. (2024) A chemical screen identifies structurally diverse metal chelators with activity against the fungal pathogen . Microbiology Spectrum. e0409523
Millimaci AM, Trilles RV, McNeely JH, et al. (2023) Synthesis of Neocannabinoids Using Controlled Friedel-Crafts Reactions. The Journal of Organic Chemistry
Naineni SK, Cencic R, Robert F, et al. (2023) Exploring the Targeting Spectrum of Rocaglates Among eIF4A Homologs. Rna (New York, N.Y.)
Kavouris JA, McCall LI, Giardini MA, et al. (2023) Discovery of pyrazolopyrrolidinones as potent, broad-spectrum inhibitors of infection. Frontiers in Tropical Diseases. 3
Shaashua L, Ben-Shmuel A, Pevsner-Fischer M, et al. (2022) BRCA mutational status shapes the stromal microenvironment of pancreatic cancer linking clusterin expression in cancer associated fibroblasts with HSF1 signaling. Nature Communications. 13: 6513
Brown LE, Seitz S, Kondas AV, et al. (2022) Identification of Small Molecules with Improved Potency against Orthopoxviruses from Vaccinia to Smallpox. Antimicrobial Agents and Chemotherapy. e0084122
Lehman SL, Wechsler T, Schwartz K, et al. (2022) Inhibition of the translation initiation factor eIF4A enhances tumor cell radiosensitivity. Molecular Cancer Therapeutics
Praditya DF, Klöhn M, Brüggemann Y, et al. (2022) Identification of structurally re-engineered rocaglates as inhibitors against hepatitis E virus replication. Antiviral Research. 105359
Xu W, Brown LE, Porco JA. (2021) Divergent, C-C Bond Forming Macrocyclizations Using Modular Sulfonylhydrazone and Derived Substrates. The Journal of Organic Chemistry
Chatterjee S, Yabaji SM, Rukhlenko OS, et al. (2021) Channeling macrophage polarization by rocaglates increases macrophage resistance to . Iscience. 24: 102845
See more...